Literature DB >> 21845516

Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis.

María Eugenia Inzaugarat1, Nazarena Eugenia Ferreyra Solari, Luis Ariel Billordo, Raquel Abecasis, Adrian C Gadano, Alejandra Claudia Cherñavsky.   

Abstract

Nonalcoholic steatohepatitis (NASH) is a chronic inflammatory liver disease associated with insulin resistance and its metabolic consequences. Leukocyte mobilization, intrahepatic activation, and an exacerbated production of reactive oxygen species (ROS) and cytokines contribute to the development of NASH. Though alterations in peripheral blood (PB) T cell proportions and functionality remain unidentified, they might play a main role in NASH progression. We have compared the phenotype and Th1/Th2 commitment of peripheral immune cell reservoirs in adult patients and controls as well as the ability of neutrophils and monocytes to handle an ex vivo challenge. Also, we correlated those parameters with the main histological characteristics in NASH. Compared with controls, patients showed increased numbers of CD4(+) cells and both CD4(+) and CD8(+) CD45RO subsets together with a higher frequency of IFN-γ-producing CD4(+) and CD8(+) T cells. We also found a decreased number of CD4(+) and CD8(+) CD45RA subsets. The distinctive production of IFN-γ highlights the significance of the observed skewed frequencies of PB T cells. Whereas ROS production by monocytes from NASH patients did not differ from controls, circulating neutrophils displayed a particularly higher phorbol myristate acetate-induced production of ROS. A negative correlation between oxidative burst and fibrosis grade was observed. This study reveals the presence of a characteristic profile of peripheral immune cells in NASH. We also discuss the probable influence of obesity on some of our present findings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21845516     DOI: 10.1007/s10875-011-9571-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  49 in total

Review 1.  Mechanisms of hepatotoxicity.

Authors:  Hartmut Jaeschke; Gregory J Gores; Arthur I Cederbaum; Jack A Hinson; Dominique Pessayre; John J Lemasters
Journal:  Toxicol Sci       Date:  2002-02       Impact factor: 4.849

Review 2.  Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2006-05       Impact factor: 4.359

Review 3.  Role of C5a in inflammatory responses.

Authors:  Ren-Feng Guo; Peter A Ward
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

5.  Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.

Authors:  Elizabeth M Brunt; David E Kleiner; Laura A Wilson; Aynur Unalp; Cynthia E Behling; Joel E Lavine; Brent A Neuschwander-Tetri
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

6.  Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.

Authors:  Tom Eirik Mollnes; Ole-Lars Brekke; Michael Fung; Hilde Fure; Dorte Christiansen; Grethe Bergseth; Vibeke Videm; Knut Tore Lappegård; Jörg Köhl; John D Lambris
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

7.  Peripheral blood lymphocyte populations in end-stage liver diseases.

Authors:  Eva M Romo; Jorge A Muñoz-Robles; Marcela Castillo-Rama; Juan C Meneu; Almudena Moreno-Elola; Baltasar Pérez-Saborido; Esther Mancebo; Sara M Calleja-Antolín; Iván Bernardo; Luis M Allende; Estela Paz-Artal
Journal:  J Clin Gastroenterol       Date:  2007-08       Impact factor: 3.062

8.  Activation of the complement system in human nonalcoholic fatty liver disease.

Authors:  Sander S Rensen; Yanti Slaats; Ann Driessen; Carine J Peutz-Kootstra; Jeroen Nijhuis; Rudi Steffensen; Jan Willem Greve; Wim A Buurman
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

9.  Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis?

Authors:  Isabelle A Leclercq
Journal:  Clin Sci (Lond)       Date:  2004-03       Impact factor: 6.124

10.  Association of lymphocyte sub-populations with clustered features of metabolic syndrome in middle-aged Japanese men.

Authors:  Takeshi Tanigawa; Hiroyasu Iso; Kazumasa Yamagishi; Isao Muraki; Noriyuki Kawamura; Akinori Nakata; Susumu Sakurai; Tetsuya Ohira; Takashi Shimamoto
Journal:  Atherosclerosis       Date:  2004-04       Impact factor: 5.162

View more
  44 in total

1.  HLA DQB1 alleles are related with nonalcoholic fatty liver disease.

Authors:  Levent Doganay; Seyma Katrinli; Yasar Colak; Ebubekir Senates; Ebru Zemheri; Oguzhan Ozturk; Feruze Yilmaz Enc; Ilyas Tuncer; Gizem Dinler Doganay
Journal:  Mol Biol Rep       Date:  2014-08-26       Impact factor: 2.316

2.  Thymic NF-κB-inducing kinase regulates CD4+ T cell-elicited liver injury and fibrosis in mice.

Authors:  Hong Shen; Liang Sheng; Yi Xiong; Yeung-Hyen Kim; Lin Jiang; Zheng Chen; Yong Liu; Kalyani Pyaram; Cheong-Hee Chang; Liangyou Rui
Journal:  J Hepatol       Date:  2017-03-06       Impact factor: 25.083

Review 3.  Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis.

Authors:  Jun Wei Lim; John Dillon; Michael Miller
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 4.  The role of neutrophils in the development of liver diseases.

Authors:  Ruonan Xu; Huihuang Huang; Zheng Zhang; Fu-Sheng Wang
Journal:  Cell Mol Immunol       Date:  2014-03-17       Impact factor: 11.530

Review 5.  Non-alcoholic fatty liver disease: what the clinician needs to know.

Authors:  Mariana Verdelho Machado; Helena Cortez-Pinto
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

6.  Is there a role for adaptive immunity in nonalcoholic steatohepatitis?

Authors:  Salvatore Sutti; Aastha Jindal; Stefania Bruzzì; Irene Locatelli; Cristina Bozzola; Emanuele Albano
Journal:  World J Hepatol       Date:  2015-07-08

7.  The role of innate cells is coupled to a Th1-polarized immune response in pediatric nonalcoholic steatohepatitis.

Authors:  Nazarena E Ferreyra Solari; María Eugenia Inzaugarat; Placida Baz; Elena De Matteo; Carol Lezama; Marcela Galoppo; Cristina Galoppo; Alejandra C Cherñavsky
Journal:  J Clin Immunol       Date:  2012-01-07       Impact factor: 8.317

Review 8.  Immune cells and metabolic dysfunction.

Authors:  Ashley Eheim; Dasa Medrikova; Stephan Herzig
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

Review 9.  The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH).

Authors:  Marina Nati; David Haddad; Andreas L Birkenfeld; Christian A Koch; Triantafyllos Chavakis; Antonios Chatzigeorgiou
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

10.  Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non-alcoholic steatohepatitis.

Authors:  Taynã Cristina Tiburcio; Joost Willebrords; Tereza Cristina da Silva; Isabel Veloso Alves Pereira; Marina Sayuri Nogueira; Sara Crespo Yanguas; Michaël Maes; Elisangela Dos Anjos Silva; Maria Lucia Zaidan Dagli; Inar Alves de Castro; Cláudia Pinto Oliveira; Mathieu Vinken; Bruno Cogliati
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-02       Impact factor: 2.557

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.